The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
1021511725 10215117 25 F 201309 20160727 20140603 20160805 EXP CA-ABBVIE-14P-028-1230114-00 ABBVIE 56.94 YR F Y 0.00000 20160805 MD COUNTRY NOT SPECIFIED CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
1021511725 10215117 1 PS HUMIRA ADALIMUMAB 1 Subcutaneous 6040687,6040688,6041043,6042179,604 125057 40 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN QOW
1021511725 10215117 2 SS HUMIRA ADALIMUMAB 1 Subcutaneous 6040687,6040688,6041043,6042179,604 125057 SOLUTION FOR INJECTION IN PRE-FILLED PEN
1021511725 10215117 3 SS PREDNISONE. PREDNISONE 1 Unknown U UNKNOWN 0
1021511725 10215117 4 SS PREDNISONE. PREDNISONE 1 Unknown U UNKNOWN 0 7.5 MG
1021511725 10215117 5 SS PREDNISONE. PREDNISONE 1 Unknown U UNKNOWN 0 7 MG
1021511725 10215117 6 C ATENOLOL. ATENOLOL 1 Oral 0 25 MG
1021511725 10215117 7 C ATENOLOL. ATENOLOL 1 Oral 0 12.5 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
1021511725 10215117 1 Uveitis
1021511725 10215117 3 Eye inflammation
1021511725 10215117 4 Therapy change
1021511725 10215117 5 Rash
1021511725 10215117 6 Blood pressure measurement

Outcome of event

Event ID CASEID OUTC COD
1021511725 10215117 OT
1021511725 10215117 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
1021511725 10215117 Atelectasis
1021511725 10215117 Back pain
1021511725 10215117 Blood creatinine increased
1021511725 10215117 Blood magnesium decreased
1021511725 10215117 Cancer pain
1021511725 10215117 Chromaturia
1021511725 10215117 Dizziness postural
1021511725 10215117 Eye inflammation
1021511725 10215117 Fall
1021511725 10215117 Fatigue
1021511725 10215117 Haemoglobin decreased
1021511725 10215117 Hypotension
1021511725 10215117 Impaired healing
1021511725 10215117 Laboratory test abnormal
1021511725 10215117 Local swelling
1021511725 10215117 Malaise
1021511725 10215117 Nodule
1021511725 10215117 Oedema
1021511725 10215117 Orthostatic hypotension
1021511725 10215117 Pain
1021511725 10215117 Pain in extremity
1021511725 10215117 Pneumonia
1021511725 10215117 Pyrexia
1021511725 10215117 Rash erythematous
1021511725 10215117 Rash macular
1021511725 10215117 Renal failure
1021511725 10215117 Renal function test abnormal
1021511725 10215117 Renal impairment
1021511725 10215117 Sarcoidosis
1021511725 10215117 Skin lesion
1021511725 10215117 Squamous cell carcinoma of skin
1021511725 10215117 Tenderness

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
1021511725 10215117 1 20130926 2015 0
1021511725 10215117 4 201309 0
1021511725 10215117 6 2014 0
1021511725 10215117 7 2014 0